http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03084985-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c72189a16a9ebb1541cb60e6f6e38c10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a48b04f986c44c2ca9129ce0b1d17c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce9ebbec86db17133c01675b4a9428b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f46a2918f21ee9971f25504738c9cd12 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107 |
filingDate | 2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f736b31e2e6e4c37ef1fc78f89259b13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fb7fdd1505e264e327d41741882d614 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba21dc48b3a9d9b6816c3cd3d0ba9a4b |
publicationDate | 2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-03084985-A1 |
titleOfInvention | Peptide chemically modified with polyethylene glycol |
abstract | It is intended to provide a peptide chemically modified with PEG which contains a sequence consisting of 18 amino acids and having a specific structure made up of four planes, i.e., two hydrophobic planes and two hydrophilic planes alternately arranged in an α-helix structural model; a complex of the above peptide with a peptide-binding substance; a carrier modified with the peptide chemically modified with PEG as described above; a process for producing the same; and a method of delivering a substance bonded to a carrier modified with the peptide chemically modified with PEG or enclosed therein. The peptide chemically modified with PEG as described above has a high safety and can be easily formulated into a complex with a peptide-binding substance (i.e., having favorable handling properties). The resultant complex has a high solubility and shows an excellent introduction selectivity of the peptide-binding substance into cells. Thus, it is available as a vector achieving a high introduction efficiency without lowering the specific activity by the chemical modification with PEG. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018111717-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021098725-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016147905-A |
priorityDate | 2002-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 634.